Alzamend Neuro Inc (ALZN)
0.67
+0.02
(+3.24%)
USD |
NASDAQ |
May 17, 16:00
0.67
0.00 (0.00%)
After-Hours: 20:00
Alzamend Neuro Total Liabilities (Quarterly): 5.046M for Jan. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 5.046M |
| October 31, 2023 | 3.666M |
| July 31, 2023 | 2.741M |
| April 30, 2023 | 2.870M |
| January 31, 2023 | 2.642M |
| October 31, 2022 | 1.638M |
| July 31, 2022 | 1.029M |
| Date | Value |
|---|---|
| April 30, 2022 | 1.165M |
| January 31, 2022 | 0.467M |
| October 31, 2021 | 1.476M |
| July 31, 2021 | 1.473M |
| April 30, 2021 | 0.8996M |
| January 31, 2021 | 2.098M |
| April 30, 2020 | 0.9923M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.467M
Minimum
Jan 2022
5.046M
Maximum
Jan 2024
2.014M
Average
1.556M
Median
Total Liabilities (Quarterly) Benchmarks
| Retractable Technologies Inc | 80.38M |
| BioCardia Inc | 4.954M |
| Summit Therapeutics Inc | 132.57M |
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 9.147M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.7826M |
| Shareholders Equity (Quarterly) | -4.264M |